These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 23102922

  • 1. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
    Lopez-Garcia P, Young Espinoza L, Molero Santos P, Marin J, Ortuño Sanchez-Pedreño F.
    Psychiatry Res; 2013 Jul 30; 208(2):118-24. PubMed ID: 23102922
    [Abstract] [Full Text] [Related]

  • 2. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M, Bechi M, Marino E, Anselmetti S, Poletti S, Cocchi F, Smeraldi E, Cavallaro R.
    Neurosci Lett; 2007 May 07; 417(3):271-4. PubMed ID: 17383818
    [Abstract] [Full Text] [Related]

  • 3. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR.
    Arch Gen Psychiatry; 2003 Sep 07; 60(9):889-96. PubMed ID: 12963670
    [Abstract] [Full Text] [Related]

  • 4. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ, Chia TY, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ, Australian Schizophrenia Research Bank.
    J Psychiatr Res; 2014 Feb 07; 49():43-50. PubMed ID: 24252819
    [Abstract] [Full Text] [Related]

  • 5. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK.
    Bipolar Disord; 2007 Jun 07; 9(4):370-6. PubMed ID: 17547583
    [Abstract] [Full Text] [Related]

  • 6. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I, Perez-Iglesias R, Pelayo-Teran JM, Rodríguez-Sanchez JM, Gonzalez-Blanch C, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B.
    Schizophr Res; 2008 Jul 07; 102(1-3):206-9. PubMed ID: 18407467
    [Abstract] [Full Text] [Related]

  • 7. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V, Gritsenko I, Alfimova M, Lebedeva I, Lezheiko T, Abramova L, Kaleda V, Ebstein R.
    World J Biol Psychiatry; 2006 Jul 07; 7(4):238-45. PubMed ID: 17071544
    [Abstract] [Full Text] [Related]

  • 8. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
    Neuhaus AH, Opgen-Rhein C, Urbanek C, Hahn E, Ta TM, Seidelsohn M, Strathmann S, Kley F, Wieseke N, Sander T, Dettling M.
    Pharmacopsychiatry; 2009 Jul 07; 42(4):141-4. PubMed ID: 19585392
    [Abstract] [Full Text] [Related]

  • 9. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
    Lopez-Garcia P, Cristobal-Huerta A, Young Espinoza L, Molero P, Ortuño Sanchez-Pedreño F, Hernández-Tamames JA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov 03; 71():176-82. PubMed ID: 27421706
    [Abstract] [Full Text] [Related]

  • 10. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
    Hoogland J, de Bie RM, Williams-Gray CH, Muslimović D, Schmand B, Post B.
    Mov Disord; 2010 Nov 15; 25(15):2550-4. PubMed ID: 20878993
    [Abstract] [Full Text] [Related]

  • 11. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia.
    Liao SY, Lin SH, Liu CM, Hsieh MH, Hwang TJ, Liu SK, Guo SC, Hwu HG, Chen WJ.
    Genes Brain Behav; 2009 Mar 15; 8(2):228-37. PubMed ID: 19077118
    [Abstract] [Full Text] [Related]

  • 12. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Leister F, Krivogorsky B, Yolken RH.
    Bipolar Disord; 2006 Apr 15; 8(2):124-32. PubMed ID: 16542182
    [Abstract] [Full Text] [Related]

  • 13. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ, Xu K, Mitropoulou V, Harvey PD, Finch T, Flory JD, New AS, Goldman D, Siever LJ.
    Psychiatr Genet; 2006 Jun 15; 16(3):117-24. PubMed ID: 16691129
    [Abstract] [Full Text] [Related]

  • 14. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
    Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, Rossi A, Pini S, Vita A, Cassano P, Stratta P, Severino G, Del Zompo M.
    Neuropsychobiology; 2005 Jun 15; 52(2):83-9. PubMed ID: 16037677
    [Abstract] [Full Text] [Related]

  • 15. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG, Machado-Vieira R, Soares Bio D, Do Prado CM, Moreno RA.
    Bipolar Disord; 2012 Aug 15; 14(5):554-64. PubMed ID: 22713126
    [Abstract] [Full Text] [Related]

  • 16. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L, Blasi G, Taurisano P, Di Giorgio A, Ferrante F, Ursini G, Fazio L, Gelao B, Romano R, Papazacharias A, Caforio G, Sinibaldi L, Popolizio T, Bellantuono C, Bertolino A.
    Psychol Med; 2013 Feb 15; 43(2):279-92. PubMed ID: 22617427
    [Abstract] [Full Text] [Related]

  • 17. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND, Jayathilake K, Meltzer HY.
    Schizophr Res; 2007 Feb 15; 90(1-3):86-96. PubMed ID: 17123785
    [Abstract] [Full Text] [Related]

  • 18. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
    Tsai SJ, Hong CJ, Liao DL, Lai IC, Liou YJ.
    Neuropsychobiology; 2004 Feb 15; 49(4):196-200. PubMed ID: 15118357
    [Abstract] [Full Text] [Related]

  • 19. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H.
    Brain; 2006 Feb 15; 129(Pt 2):399-410. PubMed ID: 16330500
    [Abstract] [Full Text] [Related]

  • 20. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls.
    Wirgenes KV, Djurovic S, Sundet K, Agartz I, Mattingsdal M, Athanasiu L, Melle I, Andreassen OA.
    Schizophr Res; 2010 Sep 15; 122(1-3):31-7. PubMed ID: 20605701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.